- Parnell introduced nixiFLOR, an injectable treatment for bovine respiratory disease in cattle.
- The product is the first FDA-approved generic version of Resflor Gold.
- nixiFLOR combines antimicrobial and anti-inflammatory action in a single subcutaneous injection.
- The FDA determined the product is bioequivalent to Resflor Gold.
- The treatment is intended for beef and non-lactating dairy cattle and requires a veterinary prescription.
Parnell Technologies announced the U.S. launch of nixiFLOR, an injectable solution containing florfenicol and flunixin meglumine approved by the U.S. Food and Drug Administration for the treatment of bovine respiratory disease and control of fever associated with the condition.
The product represents the first FDA-approved generic version of Resflor Gold and contains the same active ingredients. According to the FDA, nixiFLOR has been determined to be bioequivalent to the reference product.
Combination Therapy for Respiratory Disease in Cattle
nixiFLOR combines an antimicrobial agent with an anti-inflammatory drug in a single subcutaneous injection designed to treat bacterial respiratory infections while helping reduce fever in affected cattle.
The treatment targets common pathogens associated with bovine respiratory disease while also addressing the inflammatory response that contributes to fever and reduced performance in infected animals.
The single-dose administration is intended to simplify treatment protocols for veterinarians and cattle producers by reducing handling and labor requirements during disease management.
Addressing a Major Production Challenge
Bovine respiratory disease remains one of the most significant health challenges in cattle production, affecting herd health, productivity, and profitability.
Company officials said the availability of a bioequivalent generic product may provide producers with an additional treatment option while supporting herd health management strategies.
As with other products containing florfenicol, the medication is available by prescription only and must be administered under the supervision of a licensed veterinarian.
About Parnell
Parnell is a global veterinary pharmaceutical company focused on developing, manufacturing, and commercializing animal health products for both production and companion animals.
Information sourced from the company’s press release.
